Green Thumb Industries (GTBIF) Asset Writedowns and Impairment (2022 - 2024)
Green Thumb Industries (GTBIF) posted Asset Writedowns and Impairment of $231000.0 for Q3 2024, down 95.71% on a QoQ basis from $5.4 million in Q4 2023, and up 165.52% year-over-year from $87000.0 in Q4 2023.
Green Thumb Industries (GTBIF) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends
Green Thumb Industries' Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at $231000.0 for Q3 2024.
- Quarterly Asset Writedowns and Impairment rose 165.52% year-over-year to $231000.0 in Q3 2024, while the trailing twelve-month figure through Dec 2025 was $231000.0 (down 95.95% YoY) and the FY2024 annual result came in at $450000.0, down 91.77% from the prior year.
- Asset Writedowns and Impairment was $231000.0 for Q3 2024 at Green Thumb Industries, down from $5.4 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $88.5 million in Q4 2022 and bottomed at $87000.0 in Q3 2023.
- A 3-year average of $23.6 million and a median of $2.8 million in 2023 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment plunged 93.92% — and 2024, when it surged 165.52%.
- Green Thumb Industries' Asset Writedowns and Impairment stood at $88.5 million in 2022, then plunged by 93.92% to $5.4 million in 2023, then sank by 95.71% to $231000.0 in 2024.
- Business Quant data shows GTBIF's Asset Writedowns and Impairment at $231000.0 in Q3 2024, $5.4 million in Q4 2023, and $87000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 231,000.00 |
| Sep 30, 2024 | 231,000.00 |
| Dec 31, 2023 | 5.38 Mn |
| Dec 31, 2023 | 5.38 Mn |
| Sep 30, 2023 | 87,000.00 |
| Sep 30, 2023 | 87,000.00 |
| Dec 31, 2022 | 88.50 Mn |
| Dec 31, 2022 | 88.50 Mn |